Citation 76870

YE,Q: HE,K: OBERLIES,NH: ZENG,L: SHI,G: EVERT,D: MC LAUGHLIN,JL:. (1996). LONGIMICINS A-D: NOVEL BIOACTIVE ACETOGENINS FROM ASIMINA LONGIFOLIA (ANNONACEAE) AND STRUCTURE-ACTIVITY RELATIONSHIPS OF ASIMICIN TYPE OF ANNONACEOUS ACETOGENINS.. 39(9)

Citation Details

TitleLONGIMICINS A-D: NOVEL BIOACTIVE ACETOGENINS FROM ASIMINA LONGIFOLIA (ANNONACEAE) AND STRUCTURE-ACTIVITY RELATIONSHIPS OF ASIMICIN TYPE OF ANNONACEOUS ACETOGENINS.
AuthorsYE,Q: HE,K: OBERLIES,NH: ZENG,L: SHI,G: EVERT,D: MC LAUGHLIN,JL:
Year1996
Volume39
Issue9

Summary

Year: 1996

Journal: Unknown

Organisms and Their Experiments (1)

Asimina longifolia (ANNONACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
LONGIMICIN A
None
2
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
LONGIMICIN A
WEAK ACTIVITY
3
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN A
INACTIVE
4
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN A
ACTIVE
5
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN A
ACTIVE
6
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN A
ACTIVE
7
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN A
ACTIVE
8
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN A
ACTIVE
9
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN A
ACTIVE
10Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
LONGIMICIN B
None
11Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
LONGIMICIN C
None
12
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
LONGIMICIN B
ACTIVE
13
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN B
WEAK ACTIVITY
14
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN B
ACTIVE
15
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN B
ACTIVE
16
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN B
ACTIVE
17
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN B
ACTIVE
18
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN B
ACTIVE
19
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN B
ACTIVE
20
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
LONGIMICIN C
ACTIVE
21
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN C
WEAK ACTIVITY
22
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN C
ACTIVE
23
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN C
ACTIVE
24
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN C
ACTIVE
25
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN C
ACTIVE
26
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN C
ACTIVE
27
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN C
ACTIVE
28Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
LONGIMICIN D
None
29
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
LONGIMICIN D
ACTIVE
30
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN D
ACTIVE
31
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN D
ACTIVE
32
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN D
ACTIVE
33
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN D
STRONG ACTIVITY
34
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN D
STRONG ACTIVITY
35
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN D
STRONG ACTIVITY
36
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
LONGIMICIN D
STRONG ACTIVITY
Show SPARQL Queries (1)